Murray Valley encephalitis: a review of clinical features, diagnosis and treatment

James Knox, Raquel U Cowan, Joseph S Doyle, Matthew K Ligtermoet, John S Archer, James N C Burrow, Steven Y C Tong, Bart J Currie, John S Mackenzie, David W Smith, Mike Catton, Rodney J Moran, Craig A Aboltins and Jack S Richards
Med J Aust 2012; 196 (5): 322-326. || doi: 10.5694/mja11.11026
  • James Knox1
  • Raquel U Cowan2
  • Joseph S Doyle3
  • Matthew K Ligtermoet2
  • John S Archer4
  • James N C Burrow5
  • Steven Y C Tong5,6
  • Bart J Currie5,6
  • John S Mackenzie7,8
  • David W Smith9
  • Mike Catton3
  • Rodney J Moran10
  • Craig A Aboltins2
  • Jack S Richards1

  • 1 Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC.
  • 2 The Northern Hospital, Melbourne, VIC.
  • 3 Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC.
  • 4 Department of Medicine, Austin Health and Northern Health, University of Melbourne, Melbourne, VIC.
  • 5 Royal Darwin Hospital, Darwin, NT.
  • 6 Menzies School of Health Research, Darwin, NT.
  • 7 Faculty of Health Sciences, Curtin University, Melbourne, VIC.
  • 8 Burnet Institute, Melbourne, VIC.
  • 9 School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA.
  • 10 Investigation, Response and Policy Planning and Information Sections. Communicable Disease Prevention and Control, Department of Health, Victoria, Melbourne, VIC.


Competing interests:

No relevant disclosures.

  • 1. Miles JAR, Fowler MC, Howes DW. Isolation of a virus from encephalitis in South Australia: a preliminary report. Med J Aust 1951; 1: 799-780.
  • 2. Mackenzie JS, Broom AK. Australian X disease, Murray Valley encephalitis and the French connection. Vet Microbiol 1995; 46: 79-90.
  • 3. Bennett N. Murray Valley encephalitis: indeed a “mysterious disease”. Vic Infect Dis Bull 2008; 11: 94-107.
  • 4. Smith DW, Speers DJ, Mackenzie JS. The viruses of Australia and the risk to tourists. Travel Med Infect Dis 2011; 9: 113-125.
  • 5. Mackenzie JS, Lindsay MD, Coelen RJ, et al. Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol 1994; 136: 447-467.
  • 6. Anderson SG, Donnelley M, Stevenson WJ, et al. Murray-Valley encephalitis; surveys of human and animal sera. Med J Aust 1952; 1: 110-114.
  • 7. French EL, Anderson SG, Price AV, et al. Murray Valley encephalitis in New Guinea. I. Isolation of Murray Valley encephalitis virus from the brain of a fatal case of encephalitis occurring in a Papuan native. Am J Trop Med Hyg 1957; 6: 827-834.
  • 8. Forbes JA. Murray Valley encephalitis 1974 — also, the epidemic variance since 1914 and predisposing rainfall patterns. Sydney: Australian Medical Publishing Company, 1978.
  • 9. Nicholls N. A method for predicting Murray Valley encephalitis in southeast Australia using the Southern Oscillation. Aust J Exp Biol Med Sci 1986; 64: 587-594.
  • 10. Australian Government Department of Health and Ageing. National Notifiable Diseases Surveillance System. Canberra: 2011. (accessed July 2011).
  • 11. Hall RA, Broom AK, Hartnett AC, et al. Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. J Virol Methods 1995; 51: 201-210.
  • 12. Broom AK, Lindsay MD, Plant AJ, et al. Epizootic activity of Murray Valley encephalitis virus in an Aboriginal community in the southeast Kimberley region of Western Australia: results of cross-sectional and longitudinal serologic studies. Am J Trop Med Hyg 2002; 67: 319-323.
  • 13. Anderson SG. Murray Valley encephalitis; epidemiological aspects. Med J Aust 1952; 1: 97-100.
  • 14. Bennett NM. Murray Valley encephalitis, 1974: clinical features. Med J Aust 1976; 2: 446-450.
  • 15. Robertson EG, McLorinan H. Murray Valley encephalitis; clinical aspects. Med J Aust 1952; 1: 103-107.
  • 16. Mackenzie JS, Smith DW, Broom AK, et al. Australian encephalitis in Western Australia, 1978–1991. Med J Aust 1993; 158: 591-595.
  • 17. Burrow JN, Whelan PI, Kilburn CJ, et al. Australian encephalitis in the Northern Territory: clinical and epidemiological features, 1987–1996. Aust N Z J Med 1998; 28: 590-596.
  • 18. Cordova SP, Smith DW, Broom AK, et al. Murray Valley encephalitis in Western Australia in 2000, with evidence of southerly spread. Commun Dis Intell 2000; 24: 368-372.
  • 19. Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002; 267: 171-194.
  • 20. Wong SH, Smith DW, Fallon MJ, et al. Murray valley encephalitis mimicking herpes simplex encephalitis. <PubMed>J Clin Neurosci 2005; 12: 822-824.
  • 21. Einsiedel L, Kat E, Ravindran J, et al. MR findings in Murray Valley encephalitis. AJNR Am J Neuroradiol 2003; 24: 1379-1382.
  • 22. Kalita J, Misra UK. Comparison of CT scan and MRI findings in the diagnosis of Japanese encephalitis. J Neurol Sci 2000; 174: 3-8.
  • 23. Kastrup O, Wanke I, Maschke M. Neuroimaging of infections. NeuroRx 2005; 2: 324-332.
  • 24. Agid R, Ducreux D, Halliday WC, et al. MR diffusion-weighted imaging in a case of West Nile virus encephalitis. Neurology 2003; 61: 1821-1823.
  • 25. Kienzle N, Boyes L. Murray Valley encephalitis: case report and review of neuroradiological features. Australas Radiol 2003; 47: 61-63.
  • 26. Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology 2006; 66: 361-365.
  • 27. Broome A, McKinnon M, Miller M, et al. Interim national guidelines for the prevention, management and control of Murray Valley encephalitis. Communicable Diseases Network Australia. Canberra: Australian Government Department of Health and Ageing, 2005. (accessed Dec 2011).
  • 28. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute west nile virus infection. J Infect Dis 2008; 198: 984-993.
  • 29. McMinn PC, Carman PG, Smith DW. Early diagnosis of Murray Valley encephalitis by reverse transcriptase-polymerase chain reaction. Pathology 2000; 32: 49-51.
  • 30. Stich A, Gunther S, Drosten C, et al. Clinical and laboratory findings on the first imported case of Murray Valley encephalitis in Europe. Clin Infect Dis 2003; 37: e19-e21.
  • 31. Hills S. Murray Valley encephalitis in Mt Isa, north Queensland. Tropical Public Health Unit Network, Queensland Health. Commun Dis Intell 2001; 25: 48.
  • 32. Brown A, Bolisetty S, Whelan P, et al. Reappearance of human cases due to Murray Valley encephalitis virus and Kunjin virus in central Australia after an absence of 26 years. Commun Dis Intell 2002; 26: 39-44.
  • 33. Tilley PA, Fox JD, Jayaraman GC, et al. Nucleic acid testing for West Nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. J Infect Dis 2006; 193: 1361-1364.
  • 34. Kumar JS, Parida M, Rao PV. Monoclonal antibody-based antigen capture immunoassay for detection of circulating non-structural protein NS1: implications for early diagnosis of Japanese encephalitis virus infection. J Med Virol 2011; 83: 1063-1070.
  • 35. Alcon S, Talarmin A, Debruyne M, et al. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002; 40: 376-381.
  • 36. Chanama S, Sukprasert W, Sa-ngasang A, et al. Detection of Japanese encephalitis (JE) virus-specific IgM in cerebrospinal fluid and serum samples from JE patients. Jpn J Infect Dis 2005; 58: 294-296.
  • 37. Doherty RL, Carley JG, Filippich C, et al. Murray Valley encephalitis in Australia, 1974: antibody response in cases and community. Aust N Z J Med 1976; 6: 446-453.
  • 38. Lobigs M, Larena M, Alsharifi M, et al. Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus. J Virol 2009; 83: 2436-2445.
  • 39. Hawkes RA, Roehrig JT, Boughton CR, et al. Defined epitope blocking with Murray Valley encephalitis virus and monoclonal antibodies: laboratory and field studies. J Med Virol 1990; 32: 31-38.
  • 40. Bowen RA, Rouge MM, Siger L, et al. Pathogenesis of West Nile virus infection in dogs treated with glucocorticoids. Am J Trop Med Hyg 2006; 74: 670-673.
  • 41. Hoke CH Jr, Vaughn DW, Nisalak A, et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 1992; 165: 631-637.
  • 42. Kumar R, Tripathi P, Baranwal M, et al. Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. Clin Infect Dis 2009; 48: 400-406.
  • 43. Solomon T, Dung NM, Wills B, et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003; 361: 821-826.
  • 44. Gould EA, Solomon T, Mackenzie JS. Does antiviral therapy have a role in the control of Japanese encephalitis? Antiviral Res 2008; 78: 140-149.
  • 45. Burnell GH. The Broken Hill epidemic. Med J Aust 1917; 2: 157-161.
  • 46. Caramello P, Canta F, Balbiano R, et al. Role of intravenous immunoglobulin administration in Japanese encephalitis. Clin Infect Dis 2006; 43: 1620-1621.
  • 47. Agrawal AG, Petersen LR. Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 2003; 188: 1-4.
  • 48. Makhoul B, Braun E, Herskovitz M, et al. Hyperimmune gammaglobulin for the treatment of West Nile virus encephalitis. Isr Med Assoc J 2009; 11: 151-153.
  • 49. Ben-Nathan D, Lustig S, Tam G, et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 2003; 188: 5-12.
  • 50. Broom AK, Wallace MJ, Mackenzie JS, et al. Immunisation with gamma globulin to Murray Valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against Australian encephalitis: evaluation in a mouse model. J Med Virol 2000; 61: 259-265.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.